As of 2025-12-23, the EV/EBITDA ratio of WAVE Life Sciences Ltd (WVE) is -9.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WVE's latest enterprise value is 1,236.36 mil USD. WVE's TTM EBITDA according to its financial statements is -129.03 mil USD. Dividing these 2 quantities gives us the above WVE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 20.0x | 7.7x |
| Forward P/E multiples | 4.3x - 17.8x | 6.4x |
| Fair Price | (5.73) - (26.41) | (8.95) |
| Upside | -131.9% - -247.0% | -149.8% |
| Date | EV/EBITDA |
| 2025-12-22 | -9.58 |
| 2025-12-19 | -8.35 |
| 2025-12-18 | -8.08 |
| 2025-12-17 | -8.57 |
| 2025-12-16 | -8.62 |
| 2025-12-15 | -8.43 |
| 2025-12-12 | -8.71 |
| 2025-12-11 | -8.83 |
| 2025-12-10 | -10.98 |
| 2025-12-09 | -11.65 |
| 2025-12-08 | -9.92 |
| 2025-12-05 | -3.11 |
| 2025-12-04 | -3.19 |
| 2025-12-03 | -2.89 |
| 2025-12-02 | -2.80 |
| 2025-12-01 | -3.06 |
| 2025-11-28 | -3.27 |
| 2025-11-26 | -3.22 |
| 2025-11-25 | -3.07 |
| 2025-11-24 | -3.09 |
| 2025-11-21 | -2.84 |
| 2025-11-20 | -2.65 |
| 2025-11-19 | -2.73 |
| 2025-11-18 | -2.87 |
| 2025-11-17 | -2.90 |
| 2025-11-14 | -2.85 |
| 2025-11-13 | -2.60 |
| 2025-11-12 | -2.78 |
| 2025-11-11 | -2.96 |
| 2025-11-10 | -2.84 |
| 2025-11-07 | -3.34 |
| 2025-11-06 | -3.35 |
| 2025-11-05 | -3.45 |
| 2025-11-04 | -3.43 |
| 2025-11-03 | -3.61 |
| 2025-10-31 | -4.06 |
| 2025-10-30 | -3.61 |
| 2025-10-29 | -3.58 |
| 2025-10-28 | -3.17 |
| 2025-10-27 | -3.19 |
| 2025-10-24 | -2.88 |
| 2025-10-23 | -2.84 |
| 2025-10-22 | -2.92 |
| 2025-10-21 | -3.33 |
| 2025-10-20 | -3.30 |
| 2025-10-17 | -3.30 |
| 2025-10-16 | -3.34 |
| 2025-10-15 | -3.48 |
| 2025-10-14 | -3.35 |
| 2025-10-13 | -3.29 |